| Nom anglais | Code de recherche | Phase de R&D | Entreprise | Indication | Essai clinique |
|---|---|---|---|---|---|
| CXCR5 Modified EGFR Chimeric Antigen Receptor Autologous T Cell Therapy | Phase 1 Clinical | Second Affiliated Hospital Of Guangzhou Medical University | Carcinoma, Non-Small-Cell Lung | Details |